CHEMICAL & MINING CO OF CHILE INC financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data CHEMICAL & MINING CO OF CHILE INC files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2015	FY2017	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024
Revenue	1,728	1,939	2,157	2,266	1,944	1,817	2,862	10,711	7,467	4,529
Cost of revenue	1,186	1,328	1,395	1,486	1,384	1,334	1,772	4,974	4,392	3,202
Gross profit	543	611	763	780	560	483	1,090	5,737	3,075	1,327
Research and development				0	0
General and administrative	86.8	88.4	101	118	117	107	119	143	176	186
Operating income	369	449	618	667	434	303	927	5,531	2,844	1,066
Interest expense	69.9	57.5	50.1	57.8	76.9	82.2	84.6	86.7	138	198
Interest income	11.6	10.1	13.5	22.5	26.3	13.7	4.67	47	123	104
Pre-tax income	308	415	595	621	391	239	841	5,486	2,807	974
Income tax	83.8	133	166	179	110	70.2	249	1,572	1,877	283
Income from continuing operations	225	282	428	442	281	168	592	3,914	930	692
Net income to minority interests	4.16	3.63	0.72	2.23	2.49	3.84	6.75	7.97	7.08	6.72
Net income	220	278	428	440	278	165	585	3,906	923	685
EBITDA	96.9	699	859	887	635	506	1,142	5,776	3,125	1,408
EPS, basic	0.79	0.99	1.52	1.56	0.99	0.63	2.10	13.68	3.23	2.40
EPS, diluted	0.79	0.99	1.52	1.56	0.99	0.63	2.10	13.68	3.23	2.40

Balance sheet

	FY2015	FY2017	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024
Cash and equivalents	527	515	630	556	589	509	1,515	2,655	1,041	1,378
Short-term investments		284	361
Receivables		369	447	467	399	365	654	1,087	907	606
Inventory	1,004	993	902	914	983	1,093	1,184	1,784	1,775	1,702
Total current assets		153	2,466	2,398	2,682	2,569	4,586	6,992	5,866	5,578
Property, plant and equipment	1,684	1,533	1,429	1,455	1,570	1,737	2,012	2,727	3,610	4,434
Lease right-of-use assets				0	37.2	30	52.6	60.9	73.2	84.1
Goodwill	38.4	38	38	34.9	34.7	42	34.6	0.97	0.96	0.95
Intangible assets	110	109	114	189	188	178	180	166	156	168
Total assets	4,644	4,218	4,296	4,268	4,684	4,818	7,180	10,819	10,779	11,496
Accounts payable		200	196	164	206	204	280	375	450	471
Short-term debt		-160	164	0	0.2
Total current liabilities		580	748	556	777	476	992	3,052	2,514	2,219
Lease liabilities					25.5	25.5	46.5	49.6	57	60.8
Total liabilities	2,243	1,911	2,049	2,130	2,550	2,656	3,964	5,887	6,301	6,298
Total debt		1,550	164	1,682	2,202	2,815	4,085	4,322	5,011	6,104
Retained earnings		1,782	1,725	1,623	1,623	1,638	1,648	3,350	2,749	3,621
Shareholders' equity		2,246	2,188	2,085	2,086	2,123	3,182	4,897	4,441	5,161
Minority interests		61.2	59.6	52.3	48.2	39.5	34.5	35.4	36.2	37.2
Total equity	2,400	2,307	2,247	2,138	2,134	2,163	3,216	4,932	4,477	5,198
Total liabilities and equity	4,644	4,218	4,296	4,268	4,684	4,818	7,180	10,819	10,779	11,496

Cash flow statement

	FY2015	FY2017	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024
Net income	225	282	428	442	281	168	592	3,914	930	692
Depreciation and amortization	-272	250	241	221	201	204	214	244	281	342
Cash from operations	427	634	758	525	427	182	823	4,078	-197	1,275
Capital expenditures	-111	-131	-142	-245	-321	-322	-465	-905	-1,104	-972
Cash from investing	-69.8	162	-248	-187	-485	-167	-1,007	-909	-1,481	-1,214
Debt repaid	-190	-517	-181	-213	-7.1	-264	-14.9	-13.1	-531	-1,765
Stock issued					0	0	1,100	0	0
Dividends paid	-127	-399	-374	-550	-330	-222	-572	-2,238	-1,471	-67.2
Cash from financing	-180	-816	-412	-387	106	-94.1	1,206	-2,003	66.3	282
Exchange rate effect	-4.48	7.77	17.5	-24.9	-14.9	-0.44	-16.1	-25	-2	-6.59
Net change in cash	173	-12.6	116	-74.4	32.5	-79.4	1,006	1,140	-1,614	336
Free cash flow	316	502	616	280	106	-140	358	3,172	-1,300	303
Interest paid	44.2	55.2	51.3	59.6	71	81.6	82.8	110	121	241
Income taxes paid	72.6	114	149	240	173	201	143	1,649	2,310	235

Key metrics

Worked out from the statements above. Latest values use fiscal 2024. Valuation uses the share price of $66.89 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	29.3%	Gross profit / revenue.
Operating margin	23.5%	Operating income / revenue.
EBITDA margin	31.1%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	21.5%	Pre-tax income / revenue.
Net margin	15.1%	Net income / revenue.
FCF margin	6.7%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	28.1%	Cash from operations / revenue.
Effective tax rate	29.0%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	14.3%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	6.2%	Net income / average total assets.
Return on invested capital (ROIC)	8.3%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
Capex / revenue	21.5%	Capital expenditures / revenue.
D&A / revenue	7.6%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-39.4%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	16.5%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	18.4%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	-56.8%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	6.8%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	18.8%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	-62.5%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	4.8%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	19.7%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	-54.9%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	7.3%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	17.3%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	-25.8%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	5.4%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	19.8%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	-25.8%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	4.5%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	19.4%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow CAGR, 3y	15.7%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	24.5%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow CAGR, 3y	-5.4%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	23.4%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	16.2%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	17.5%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	19.9%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	6.6%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	17.0%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	19.7%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	2.51x	Current assets / current liabilities.
Quick ratio	0.89x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.62x	(Cash + short-term investments) / current liabilities.
Debt / equity	1.18x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	53.1%	Total debt / total assets.
Liabilities / assets	54.8%	Total liabilities / total assets.
Net debt	$4.73B	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	3.36x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	5.40x	Operating income / interest expense.
Working capital	$3.36B	Current assets - current liabilities.
Goodwill and intangibles / assets	1.5%	(Goodwill + intangible assets) / total assets.
Tangible book value	$4.99B	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.41x	Revenue / average total assets.
Fixed asset turnover	1.13x	Revenue / average property, plant and equipment.
Inventory turnover	1.84x	Cost of revenue / average inventory.
Days inventory	198 days	365 x average inventory / cost of revenue.
Receivables turnover	5.99x	Revenue / average receivables.
Days sales outstanding	61 days	365 x average receivables / revenue.
Days payables	53 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	207 days	Days inventory + days sales outstanding - days payables.
FCF conversion	44.2%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	76.2%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$2.40	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic	$2.40	Net income per basic share, as reported (split-adjusted).
Payout ratio	9.8%	Dividends paid / net income, when net income is positive.
Dividends / FCF	22.2%	Dividends paid / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$19.11B	Share price x shares outstanding.
Enterprise value	$23.83B	Market cap + total debt - cash - short-term investments.
P/E	27.9x	Market cap / net income. Only when net income is positive.
P/S	4.22x	Market cap / revenue.
P/B	3.70x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	3.83x	Market cap / tangible book value, when positive.
P/FCF	63.1x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	15.0x	Market cap / cash from operations, when positive.
EV/Sales	5.26x	Enterprise value / revenue.
EV/EBIT	22.4x	Enterprise value / operating income, when both are positive.
EV/EBITDA	16.9x	Enterprise value / EBITDA, when both are positive.
EV/FCF	78.7x	Enterprise value / free cash flow, when both are positive.
FCF yield	1.6%	Free cash flow / market cap.
Earnings yield	3.6%	Net income / market cap (the inverse of P/E).
Dividend yield	0.4%	Dividends paid over the period / market cap.
Shareholder yield	0.4%	(Dividends paid + share buybacks) / market cap.
PEG	6.26x	P/E / EPS growth per year over 3 years (in percent). Only when both are positive.

What was CHEMICAL & MINING CO OF CHILE INC's revenue in fiscal 2024?

CHEMICAL & MINING CO OF CHILE INC reported revenue of $4.53B for fiscal 2024, 39.4% lower than the year before.

Was CHEMICAL & MINING CO OF CHILE INC profitable in fiscal 2024?

Yes. Net income was $685.1M, a net margin of 15.1%.

How much free cash flow did CHEMICAL & MINING CO OF CHILE INC generate in fiscal 2024?

Cash from operations of $1.27B minus capital expenditures of $971.8M left free cash flow of $302.9M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to CHEMICAL & MINING CO OF CHILE INC